Navigation Links
Doctors Still Deny Older Patients Tests and Treatment

Doctors are still denying older people the sorts of tests and treatment they would offer to younger patients, reveals a survey// in Quality and Safety in Health Care.

Half of those surveyed were influenced by a patient’s age in their decisions on whether to send a patient for tests or prescribe treatment. Patients over 65 were managed differently from those who were younger.

The findings are based on a survey of almost 90 general practitioners, specialists in care of the elderly, and cardiologists from across Southern England and the Midlands.

Participants were specifically quizzed about their intended management of 72 fictional patients with angina, using a specially devised computer programme, and face to face structured interviews.

The fictional patients were all aged between 45 and 92, with varying degrees of severity of heart problems. Head and shoulders photographs of people who had agreed to be the fictional patients were also provided.

Overall, older patients were less likely to be referred to a cardiologist and given an angiogram or exercise tolerance tests as middle aged patients. They were also less likely to be given revascularisation (opening up of blood vessels).

But they were significantly more likely to have their medication changed and told to come back at a later date.

Half of the doctors in each of the three professional groups treated older patients differently. Those who were influenced by a patient’s age were on average five years older then those who were not.

The face to face interviews revealed various reasons for differences in treatment, some of which related to patients’ wishes, potential complications of treatment and the frailty of the individual concerned.

Two doctors deliberately dissociated the influence of these factors from that of old age.

One doctor commented: “I’d like to think that I would treat the individual . I think generally you have to try and identify from an individual what is in their best interests. I don’t think bypass surgery in an 87 year old is in their interests.”

Source-NewswiseSRM
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Emphasis to ban Drugs ads by Doctors
7. Doctors not to accept gifts from drug companies
8. Gene testing kit specific for Doctors
9. Doctors warned of fluoride toxicity
10. Doctors decisions are affected by fear of lawsuits- says a study
11. Bihar High Court Intervenes To End Doctors Strike
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... With ... intervention to walk, the demand for a sustainable product to aid in the rehabilitation ... and aid in the recovery of individuals with hemiplegia due to stroke. , Ekso ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
(Date:5/26/2016)... ... 2016 , ... Cabot Corporation, Pfizer, and 3M are responsible ... documents and SEC filings. A jury has returned a verdict of $32.8 ... Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 million in ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... LifeScienceIndustryResearch.com adds "Ulcerative Colitis ... with comprehensive information on the therapeutic development for ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Ulcerative Colitis ...
(Date:5/27/2016)... -- Hutchison China MediTech (Chi-Med) (HCM) ... highly lucrative global oncology and immunology markets. HCM ... or best-in-class tyrosine kinase inhibitor (TKI) drugs, some ... HCM,s profitable Chinese healthcare business continues to benefit ... of the mid-to-late-stage pipeline during 2016-17 (including US ...
(Date:5/26/2016)... India , May 26, 2016 ... drugs market growth is the emergence of new treatments. ... astaxanthin therapies for osteoarthritis treatment. The therapy is expected ... Moreover, Arthritis Research UK is conducting studies to develop ... arcOGEN study, where the genes involved in osteoarthritis are ...
Breaking Medicine Technology: